Stocktoria
Genus plc GNS.L
Genus plc (GNS.L) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 1.41% (safety: n/a).
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Healthcare · percentile among 80 companies
Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.137 |
| Retained earnings / assets | 0.358 |
| EBIT / assets | 0.047 |
| Equity / liabilities | 1.124 |
About Genus plc
Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as technical services and advice under the PIC brand. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.
FAQ
Is GNS.L financially healthy?
Genus plc's Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does GNS.L pay a dividend, and is it safe?
Yes. Genus plc pays a dividend yielding about 1.41% with a None payout ratio, rated “n/a” for safety.
Is GNS.L overvalued or undervalued?
Genus plc trades at about 9170.7× trailing earnings — near its 10-year norm (10-year range 4562.7×–15344.5×, median 10142.3×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for GNS.L?
The average Wall-Street price target for Genus plc is £3,128.17, about 38.7% above the recent price, from 12 analysts.
Is GNS.L a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Genus plc: a Piotroski F-score of 4/9, an Altman Z″ in the safe zone, a dividend yield of 1.41%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · GB · as of 2025-06-30. Figures in GBP. Facts plus Stocktoria's own computed scores — not investment advice.